A Two-Part randomized, Double-Blind, Placebo-Controlled study to assess the safety, tolerability and pharmacokinetics of single ascending and multiple ascending oral doses of SRP-3D (DA), and to characterize the effect of food on the pharmacokinetics of SRP-3D (DA), in healthy male and female subjects
Completed
This is a two-part randomized, double-blind, placebo-controlled study.
Phase 1 • Sponsor: South Rampart Pharma, Inc.
Last updated Sep 10, 2026 16:00 UTC